Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.8000
+0.0300 (3.90%)
At close: Mar 6, 2026
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 468.28 million as of March 6, 2026. Its market cap has decreased by -84.66% in one year.
Market Cap
468.28M
Enterprise Value
-264.77M
Revenue
706.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 468.28M, a decrease of -91.02%. That is a compound annual growth rate of -46.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 468.28M | -19.19% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 70.45B |
| Guanze Medical Information Industry (Holding) | 3.60B |
| Adicon Holdings | 3.29B |
| Mega Genomics | 1.56B |
| Kindstar Globalgene Technology | 1.14B |
| Biosino Bio-Technology and Science Incorporation | 764.05M |
| China Biotech Services Holdings | 683.01M |
| King International Investment | 198.00M |